Leukemia Clinical Trials in Atlanta

Showing 1201-1220 of 1,466 trials

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

NCT02276560

The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.

Stage IIIA Non-Small Cell Lung Cancer

UNC Lineberger Comprehensive Cancer Center1 participantsStarted Jan 2015

Tampa, Florida, United States • Atlanta, Georgia, United States • Kansas City, Kansas, United States +6 more locations

COMPLETEDPhase 2< 1 mile

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01868893

This is a multicenter, open-label, single-arm, expanded access treatment study designed to provide obinutuzumab to patients with previously untreated Chronic Lymphocytic Leukemia (CLL) in combination with chlorambucil and to evaluate the safety and efficacy of obinutuzumab administered in combination with chlorambucil. This study will enroll patients with previously untreated CD20-positive CLL requiring treatment according to the IWCLL guidelines (Hallek et al 2008), as assessed by the investigator.

Chronic Lymphocytic Leukemia

Genentech, Inc.20 participantsStarted Aug 2013

Huntsville, Alabama, United States • Rogers, Arkansas, United States • La Jolla, California, United States +16 more locations

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Leukemia Trials in Other Cities

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Study of the Glutaminase Inhibitor CB-839 in Leukemia

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

Other Conditions in Atlanta